These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 561703)

  • 41. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical effects of baclofen (beta-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain.
    Andén NE; Wachtel H
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):310-20. PubMed ID: 576560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration.
    Weick BG; Engber TM; Susel Z; Chase TN; Walters JR
    Brain Res; 1990 Jul; 523(1):16-22. PubMed ID: 2119854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.
    Yurek DM; Hipkens SB
    Brain Res; 1994 Mar; 639(2):329-32. PubMed ID: 7911393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulatory effects of baclofen muscimol and GABA on interspecific aggressive behaviour in the rat.
    Delini-Stula A; Vassout A
    Neuropharmacology; 1978 Dec; 17(12):1063-5. PubMed ID: 570649
    [No Abstract]   [Full Text] [Related]  

  • 46. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.
    Kelly PH; Moore KE
    Neuropharmacology; 1978 Mar; 17(3):169-74. PubMed ID: 643163
    [No Abstract]   [Full Text] [Related]  

  • 49. Central GABA receptor agonists: comparison of muscimol and baclofen.
    Naik SR; Guidotti A; Costa E
    Neuropharmacology; 1976 Aug; 15(8):479-84. PubMed ID: 185540
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1979 Sep; 58(2):133-40. PubMed ID: 499343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interaction of baclofen (beta-(4-chlorophenyl)Gaba) with GABA systems in rat brain: evidence for a releasing action.
    Roberts PJ; Gupta HK; Shargill NS
    Brain Res; 1978 Oct; 155(1):209-12. PubMed ID: 210894
    [No Abstract]   [Full Text] [Related]  

  • 53. GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB.
    Giralt MT; Bonanno G; Raiteri M
    Eur J Pharmacol; 1990 Jan; 175(2):137-44. PubMed ID: 2155793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
    Engberg G; Kling-Petersen T; Nissbrandt H
    Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
    Waddington JL; Cross AJ
    Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR; Lee LA; Slater P
    Br J Pharmacol; 1977 Nov; 61(3):483P. PubMed ID: 563262
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
    Waldmeier PC; Feldtrauer JJ; Kam R; Stöcklin K
    Eur J Pharmacol; 1979 Mar; 54(3):279-87. PubMed ID: 428427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of microinjections of neurotoxin AvTx8, isolated from the social wasp Agelaia vicina (Hymenoptera, Vespidae) venom, on GABAergic nigrotectal pathways.
    de Oliveira L; Cunha AO; Mortari MR; Pizzo AB; Miranda A; Coimbra NC; dos Santos WF
    Brain Res; 2005 Jan; 1031(1):74-81. PubMed ID: 15621014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord.
    Sawynok J; Dickson C
    Pharmacology; 1985; 31(5):248-59. PubMed ID: 2999839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.